Wolfe Research raised the firm’s price target on Amazon.com to $270 from $250 and keeps an Outperform rating on the shares as part of a 2025 outlook for the internet group. 2025 could be another ...

Rolex watches, which aren't known for their affordability, are getting even more expensive this year with the soaring price of gold to blame. Prices on some of the Swiss company's gold watches jumped ...

At their peak in April, prices for the ingredient surpassed $12,000 per tonne, which was an almost threefold increase from January, the FT reported. Cocoa prices have soared due to poor climate ...

The provider, which is the largest private broadband company in America, has confirmed price hikes are coming in January. Cox declined to provide specifics of the exact fees that will be ...

National house prices were down by 0.17 per cent in December, according to the latest data from PropTrack. However the small decline has done little to curb the market’s overall upward ...

11 minutes Perovskites, a ‘dirt cheap’ alternative to silicon, just got a lot more efficient Tsvetana is a writer for Oilprice.com with over a decade of experience writing for news outlets ...

Ruger hopped on the long-range precision rifle craze when it introduced its ... that offered quality and accuracy at an affordable price. New for 2025, the company is introducing an updated ...

With the fluctuating costs of materials and the absence of technical staff, it is increasingly important to optimize your workflow and utilize equipment to the best of its ability. This webinar will ...

Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer PFE.N COVID-19 treatment Paxlovid, Bristol Myers Squibb's BMY.N cancer cell therapies and vaccines ...

Global house prices are expected to rise in the next two years, according to Fitch Ratings. "Nominal home prices will grow in the low to mid-single digits for most countries in each of the next ...

BTIG raised the firm’s price target on Insulet (PODD) to $300 from $270 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models in select Medical ...

NEW YORK, Dec 31 (Reuters) - Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer (PFE.N), opens new tab COVID-19 treatment Paxlovid, Bristol Myers Squibb's ...